NIH-funded research NIH-funded research

How mitochondrial, lysosome, and immune problems affect dry age-related macular degeneration

Official title: The mechanistic role of the interconnected mitochondrial-lysosomal-immune dysfunction axis in early, dry AMD

Funded at Johns Hopkins University · NIH-11609399 · Data updated 2026-11-12

This grant looks at how stress in eye cells’ powerhouses, waste disposal systems, and immune signals may contribute to early dry AMD in people who carry specific genetic risk.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startSeptember 4, 2026
Project endAugust 31, 2027
Funding year2026
Award (this year)$773,165
NIH project number1R56EY037703-01A1
Project IDNIH-11609399 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with AMD risk factors, including the CFHY402H variant, and access to patient-derived iPSC-RPE cells.

Less likely to help

People without AMD risk variants or those not willing to provide cells or samples may not benefit.

What this research studies

Researchers will study eye cells derived from patients to see how mitochondrial and lysosome problems trigger immune signals that could damage the retina. They will focus on the CFHY402H genetic variant and how it worsens harmful processes inside retinal pigment epithelium cells. The project uses patient-derived cells to model the disease mechanism and test the chain of events leading to vision loss. If the mechanism is clarified, it could point to new ways to slow or prevent progression in people at risk.

Why it matters

Potential benefit: Understanding these pathways could lead to new targets for preventing or delaying vision loss in people with AMD, especially those with the CFHY402H risk variant.

How similar studies have gone: precedent in iPSC-derived retinal models supports studying disease pathways, but direct links to CFH variant–driven cGAS/STING activation are still being explored.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Sinha, Debasish — Johns Hopkins University
  • Study coordinator: Sinha, Debasish

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.